Our strategic alliance, the Consorcio DTx, aims to advance the regulation of digital therapeutics (DTx) and facilitate their access to the Spanish medical devices market.
We are a national entity with an associative base, created as a result of the lack of accessibility to therapeutic innovations related to digital treatments through the national health system. We have a clear vocation to promote collaboration between people, companies and relevant entities in the healthcare ecosystem to jointly speed up the adoption of these processes.
To speed up the implementation of digital therapeutics in Spain by generating a specific regulatory framework for the country through the analysis of relevant experiences in pioneering countries and intersectoral co-creation with the main players in the ecosystem (Administration, healthcare professionals, patients, carers, companies, startups, hospitals, etc.).
Transform health services through the adoption of digital therapeutics that improve clinical outcomes and optimise the efficiency of the health system.
the know-how (do’s & don’ts) of the most advanced countries in the adoption of digital therapies (such as Germany, UK, France or Belgium) to relevant agents of the Public Administration.
a network of experts in the development, implementation and integration of digital therapeutic innovations in the healthcare ecosystem.
a project to generate evidence through collaboration between different actors, as well as to jointly consider the needs and points of view in a cross-cutting way to facilitate the adoption of the model.
an outline of a Spanish regulatory model, in line with European guidelines and based on experiences in pioneering countries, to speed up access and reimbursement of digital therapeutics.
Pharma/Biotech
MedTech
Telecommunications
Technology
Insurance
CROs
Investment funds
Digital health
Digital therapy
Patient associations
Scientific societies
Hospitals or foundations
Innovation hubs
Other
© 2022 Created by Consorcio DTx
